|
1
|
Task Force on Myocardial Revascularization
of The European Society of Cardiology (ESC), the European
Association for Cardio-Thoracic Surgery (EACTS)1; European
Association for Percutaneous Cardiovascular Interventions (EAPCI),
; Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, Garg
S, Huber K, et al: Guidelines on myocardial revascularization. Eur
Heart J. 31:2501–2555. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Keeley EC, Boura JA and Grines CL: Primary
angioplasty versus intravenous thrombolytic therapy for acute
myocardial infarction: A quantitative review of 23 randomised
trials. Lancet. 361:13–20. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Capes SE, Hunt D, Malmberg K and Gerstein
HC: Stress hyperglycaemia and increased risk of death after
myocardial infarction in patients with and without diabetes: A
systematic overview. Lancet. 355:773–778. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Straumann E, Kurz DJ, Muntwyler J,
Stettler I, Furrer M, Naegeli B, Frielingsdorf J, Schuiki E, Mury
R, Bertel O and Spinas GA: Admission glucose concentrations
independently predict early and late mortality in patients with
acute myocardial infarction treated by primary or rescue
percutaneous coronary intervention. Am Heart J. 150:1000–1006.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Timmer JR, Hoekstra M, Nijsten MW, van der
Horst IC, Ottervanger JP, Slingerland RJ, Dambrink JH, Bilo HJ,
Zijlstra F and van't Hof AW: Prognostic value of admission
glycosylated hemoglobin and glucose in nondiabetic patients with
ST-segment-elevation myocardial infarction treated with
percutaneous coronary intervention. Circulation. 124:704–711. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yang Y, Kim TH, Yoon KH, Chung WS, Ahn Y,
Jeong MH, Seung KB, Lee SH and Chang K: The stress hyperglycaemia
ratio, an index of relative hyperglycaemia, as a predictor of
clinical outcomes after percutaneous coronary intervention. Int J
Cardiol. 241:57–63. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kim EJ, Jeong MH, Kim JH, Ahn TH, Seung
KB, Oh DJ, Kim HS, Gwon HC, Seong IW, Hwang KK, et al: KAMIR-NIH
registry investigators: Clinical impact of admission hyperglycaemia
on in-hospital mortality in acute myocardial infarction patients.
Int J Cardiol. 236:9–15. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kosuge M, Kimura K, Kojima S, Sakamoto T,
Matsui K, Ishihara M, Asada Y, Tei C, Miyazaki S, Sonoda M, et al:
Effects of glucose abnormalities on in-hospital outcome after
coronary intervention for acute myocardial infarction. Circ J.
69:375–379. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Worthley MI, Holmes AS, Willoughby SR,
Kucia AM, Heresztyn T, Stewart S, Chirkov YY, Zeitz CJ and Horowitz
JD: The deleterious effects of hyperglycaemia on platelet function
in diabetic patients with acute coronary syndromes mediation by
superoxide production, resolution with intensive insulin
administration. J Am Coll Cardiol. 49:304–310. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ray KK, Cannon CP, Morrow DA, Kirtane AJ,
Buros J, Rifai N, McCabe CH, Gibson CM and Braunwald E: Synergistic
relationship between hyperglycaemia and inflammation with respect
to clinical outcomes in non-ST-elevation acute coronary syndromes:
Analyses from OPUS-TIMI 16 and TACTICS-TIMI 18. Eur Heart J.
28:806–813. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ikeda U, Matsui K, Murakami Y and Shimada
K: Monocyte chemoattractant protein-1 and coronary artery disease.
Clin Cardiol. 25:143–147. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
de Léséleuc L, Orlova M, Cobat A, Girard
M, Huong NT, Ba NN, Thuc NV, Truman R, Spencer JS, Adams L, et al:
PARK2 mediates interleukin 6 and monocyte chemoattractant protein 1
production by human macrophages. PLoS Negl Trop Dis. 7:e20152013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu L, Gao XJ, Ren CG, Hu JH, Liu XW,
Zhang P, Zhang ZW and Fu ZJ: Monocyte chemoattractant protein-1
contributes to morphine tolerance in rats with cancer-induced bone
pain. Exp Ther Med. 13:461–466. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cipollone F, Marini M, Fazia M, Pini B,
Iezzi A, Reale M, Paloscia L, Materazzo G, D'Annunzio E, Conti P,
et al: Elevated circulating levels of monocyte chemoattractant
protein-1 in patients with restenosis after coronary angioplasty.
Arterioscler Thromb Vasc Biol. 21:327–334. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Heil M, Ziegelhoeffer T, Wagner S,
Fernández B, Helisch A, Martin S, Tribulova S, Kuziel WA, Bachmann
G and Schaper W: Collateral artery growth (arteriogenesis) after
experimental arterial occlusion is impaired in mice lacking
CC-chemokine receptor-2. Circ Res. 94:671–677. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Thygesen K, Alpert JS, Jaffe AS, Simoons
ML, Chaitman BR, White HD, Thygesen K, Alpert JS, White HD; Writing
Group on the Joint ESC/ACCF/AHA/WHF Task Force for the Universal
Definition of Myocardial Infarction, ; et al: Third universal
definition of myocardial infarction. Eur Heart J. 33:2551–2567.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yuen VG and McNeill JH: Comparison of the
glucose oxidase method for glucose determination by manual assay
and automated analyzer. J Pharmacol Toxicol Methods. 44:543–546.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
American Diabetes Association: Standards
of medical care in diabetes-2014. Diabetes Care. 37 (Suppl
1):S14–S80. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ponikowski P, Voors AA, Anker SD, Bueno H,
Cleland JGF, Coats AJS, Falk V, González-Juanateyr JR, Harjola VP,
Jankowska EA, et al: 2016 ESC Guidelines for the diagnosis and
treatment of acute and chronic heart failure: The Task Force for
the diagnosis and treatment of acute and chronic heart failure of
the European Society of Cardiology (ESC). Developed with the
special contribution of the Heart Failure Association (HFA) of the
ESC. Eur J Heart Fail. 18:891–975. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang C, Li F, Guo J, Li C, Xu D and Wang
B: Insulin resistance, blood glucose and inflammatory cytokine
levels are risk factors for cardiovascular events in diabetic
patients complicated with coronary heart disease. Exp Ther Med.
15:1515–1519. 2018.PubMed/NCBI
|
|
21
|
Xu W, Tian M and Zhou Y: The relationship
between insulin resistance, adiponectin and C-reactive protein and
vascular endothelial injury in diabetic patients with coronary
heart disease. Exp Ther Med. 16:2022–2026. 2018.PubMed/NCBI
|
|
22
|
Antoniucci D, Valenti R, Migliorini A,
Parodi G, Moschi G, Memisha G, Santoro GM and Cerisano G: Impact of
insulin-requiring diabetes mellitus on effectiveness of reperfusion
and outcome of patients undergoing primary percutaneous coronary
intervention for acute myocardial infarction. Am J Cardiol.
93:1170–1172. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Timmer JR, van der Horst IC, de Luca G,
Ottervanger JP, Hoorntje JC, de Boer MJ, Suryapranata H, Dambrink
JH, Gosselink M, Zijlstra F, et al: Zwolle Myocardial Infarction
Study Group: Comparison of myocardial perfusion after successful
primary percutaneous coronary intervention in patients with
ST-elevation myocardial infarction with versus without diabetes
mellitus. Am J Cardiol. 95:1375–1377. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Prasad A, Stone GW, Stuckey TD, Costantini
CO, Zimetbaum PJ, McLaughlin M, Mehran R, Garcia E, Tcheng JE, Cox
DA, et al: Impact of diabetes mellitus on myocardial perfusion
after primary angioplasty in patients with acute myocardial
infarction. J Am Coll Cardiol. 45:508–514. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Knudsen EC, Seljeflot I, Abdelnoor M,
Eritsland J, Mangschau A, Arnesen H and Andersen GO: Abnormal
glucose regulation in patients with acute ST-elevation myocardial
infarction-a cohort study on 224 patients. Cardiovasc Diabetol.
8:62009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Terlecki M, Bryniarski L, Bednarek A,
Kocowska M, Kawecka-Jaszcz K and Czarnecka D: The risk of diabetes
development in long-term observation of patients with acute
hyperglycaemia during myocardial infarction. Kardiol Pol.
73:606–612. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ishihara M, Inoue I, Kawagoe T, Shimatani
Y, Kurisu S, Hata T, Nakama Y, Kijima Y and Kagawa E: Is admission
hyperglycaemia in non-diabetic patients with acute myocardial
infarction a surrogate for previously undiagnosed abnormal glucose
tolerance? Eur Heart J. 27:2413–2419. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ishihara M: Acute hyperglycemia in
patients with acute myocardial infarction. Circ J. 76:563–571.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Roberts GW, Quinn SJ, Valentine N,
Alhawassi T, O'Dea H, Stranks SN, Burt MG and Doogue MP: Relative
hyperglycemia, a marker of critical illness: Introducing the stress
hyperglycemia ratio. J Clin Endocrinol Metab. 100:4490–4497. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Younce CW, Wang K and Kolattukudy PE:
Hyperglycaemia-induced cardiomyocyte death is mediated via MCP-1
production and induction of a novel zinc-finger protein MCPIP.
Cardiovasc Res. 87:665–674. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Marfella R, Siniscalchi M, Esposito K,
Sellitto A, De Fanis U, Romano C, Portoghese M, Siciliano S, Nappo
F, Sasso FC, et al: Effects of stress hyperglycemia on acute
myocardial infarction: Role of inflammatory immune process in
functional cardiac outcome. Diabetes Care. 26:3129–3135. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Birdsall HH, Green DM, Trial J, Youker KA,
Burns AR, MacKay CR, LaRosa GJ, Hawkins HK, Smith CW, Michael LH,
et al: Complement C5a, TGF-beta 1, and MCP-1, in sequence, induce
migration of monocytes into ischemic canine myocardium within the
first one to five hours after reperfusion. Circulation. 95:684–692.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Niu J, Jin Z, Kim H and Kolattukudy PE:
MCP-1-induced protein attenuates post-infarct cardiac remodeling
and dysfunction through mitigating NF-κB activation and suppressing
inflammation-associated microRNA expression. Basic Res Cardiol.
110:262015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zietz B, Büchler C, Herfarth H,
Müller-Ladner U, Spiegel D, Schölmerich J and Schäffler A:
Caucasian patients with type 2 diabetes mellitus have elevated
levels of monocyte chemoattractant protein-1 that are not
influenced by the −2518 A->G promoter polymorphism. Diabetes
Obes Metab. 7:570–578. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Piemonti L, Calori G, Lattuada G, Mercalli
A, Ragogna F, Garancini MP, Ruotolo G, Luzi L and Perseghin G:
Association between plasma monocyte chemoattractant protein-1
concentration and cardiovascular disease mortality in middle-aged
diabetic and nondiabetic individuals. Diabetes Care. 32:2105–2110.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tenerz A, Norhammar A, Silveira A, Hamsten
A, Nilsson G, Rydén L and Malmberg K: Diabetes, insulin resistance,
and the metabolic syndrome in patients with acute myocardial
infarction without previously known diabetes. Diabetes Care.
26:2770–2776. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
El-Osta A, Brasacchio D, Yao D, Pocai A,
Jones PL, Roeder RG, Cooper ME and Brownlee M: Transient high
glucose causes persistent epigenetic changes and altered gene
expression during subsequent normoglycemia. J Exp Med.
205:2409–2417. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ishihara M, Kojima S, Sakamoto T, Asada Y,
Tei C, Kimura K, Miyazaki S, Sonoda M, Tsuchihashi K, Yamagishi M,
et al: Acute hyperglycemia is associated with adverse outcome after
acute myocardial infarction in the coronary intervention era. Am
Heart J. 150:814–820. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Iwakura K, Ito H, Ikushima M, Kawano S,
Okamura A, Asano K, Kuroda T, Tanaka K, Masuyama T, Hori M and
Fujii K: Association between hyperglycemia and the no-reflow
phenomenon in patients with acute myocardial infarction. J Am Coll
Cardiol. 41:1–7. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ota S, Tanimoto T, Orii M, Hirata K,
Shiono Y, Shimamura K, Matsuo Y, Yamano T, Ino Y, Kitabata H, et
al: Association between hyperglycemia at admission and
microvascular obstruction in patients with ST-segment elevation
myocardial infarction. J Cardiol. 65:272–277. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Pak S, Yatsynovich Y and Markovic JP: A
meta-analysis on the correlation between admission hyperglycemia
and myocardial infarct size on CMRI. Hellenic J Cardiol.
59:174–178. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ishihara M, Inoue I, Kawagoe T, Shimatani
Y, Kurisu S, Nishioka K, Umemura T, Nakamura S and Yoshida M:
Impact of acute hyperglycemia on left ventricular function after
reperfusion therapy in patients with a first anterior wall acute
myocardial infarction. Am Heart J. 146:674–678. 2003. View Article : Google Scholar : PubMed/NCBI
|
